| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.01B | +7.9% |
| Cost of Revenue | $468.7M | +4.0% |
| Gross Profit | $546.0M | +11.5% |
| R&D Expense | $193.1M | -2.9% |
| SG&A Expense | $445.0M | +14.2% |
| Operating Income | -$187.3M | -88.9% |
| Pre-tax Income | -$200.3M | -118.0% |
| Income Tax | $4.4M | +6.8% |
| Net Income | -$204.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.6M | +30.9% |
| Short-term Investments | $202.0M | -45.3% |
| Accounts Receivable | $165.5M | +44.4% |
| Inventory | $128.8M | -13.9% |
| Current Assets | $618.1M | -14.7% |
| Total Assets | $881.1M | -8.9% |
| Current Liabilities | $242.7M | -1.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.7M | -140.1% |
| Capital Expenditures | $19.9M | +3.7% |
| Investing Cash Flow | $72.9M | +410.3% |
| Financing Cash Flow | -$43.4M | -618.3% |
| Free Cash Flow | -$29.7M | -694.1% |
| -113.2% |
| EPS (Basic) | -$3.04 | -106.8% |
| EPS (Diluted) | -$3.04 | -106.8% |
| Long-term Debt |
| $310.0M |
| +0.6% |
| Total Liabilities | $725.9M | +3.0% |
| Stockholders' Equity | $155.2M | -41.0% |